Lonizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering

Investigators reported the development of an ionizable lipid nanoparticle platform for simultaneous therapeutic mRNA expression and RNAi-mediated transient gene knockdown in T cells.